





To the Editor: Coronaviruses 
(CoVs) are enveloped, positive-sense, 
single-stranded RNA viruses that can 
cause acute and chronic respiratory, 
enteric, and central nervous system 
disease in a variety of animal species 
(1). Recently, a novel ferret enteric 
CoV (FRECV) was indentifi ed 
in domesticated ferrets (Mustela 
putorius) in which epizootic catarrhal 
enteritis had been diagnosed; the 
illness was characterized by foul-
smelling green diarrhea with high 
mucus content, lethargy, anorexia, 
and vomiting (2). Another ferret CoV 
emerged in ferrets for which systemic 
pyogranulomatous infl ammation, 
resembling the clinical and pathologic 
features of feline infectious peritonitis 
(FIP), was diagnosed (3–5).
In 2010, we investigated the 
prevalence of CoV antibodies in 85 
asymptomatic ferrets obtained from 
1 ferret farm in the Netherlands. 
Previous studies have shown that 
antibodies against different members 
of the α-CoVs show broad cross-
reactivity (6). We used FIP virus 
(FIPV)–infected cells to screen 
for CoV antibodies in an indirect 
immunoperoxidase assay. Because 
32% of the ferret serum had a titer >20 
in this assay, we concluded that these 
animals most likely had been exposed 
to a CoV. To test for a CoV in these 
animals, we analyzed RNA extracted 
from rectal swabs with a degenerate 
set of primers to amplify a conserved 
region within open reading frame 
(ORF) 1 of CoVs (7). Remarkably, 
36 (42%) of samples tested were PCR 
positive, suggesting excretion of a 
CoV by a substantial proportion of 
ferrets tested. To corroborate that the 
CoV detected in the rectal swabs was 
a ferret CoV (FRCoV), we amplifi ed 
and sequenced the nucleocapsid 
protein by using primer pair 5′- TCCC
CGCGGGGCTGGCAACGGACAA
CGTGT-3′ and 5′-CCCAAGCTTTTA
G T T G A C TA ATA AT T T C A - 3 ′ . 
Phylogenetic analyses of 2 of the 
sequences obtained indicated a variant 
nucleocapsid that was similar to other 
FRCoVs described previously but 
that did not group with 1 of these 
sequences directly (Figure). Amino 
acid alignment of 1 of these sequences 
(FRCoV-511c) with FRECV-MSU2 
demonstrated 91.8% identity and 
95.7% similarity, whereas this virus 
shows 89.3% identity and 95.2% 
similarity to ferret systemic CoV 
(FRSCV-MSU1).
On the basis of obtained and 
published nucleocapsid sequences 
(2,4), we developed a TaqMan 
reverse transcription PCR to detect 
viral RNA using the following 
primers and degenerate probe: 
fo rward ,5 ′ -TTGGAAAGAATG
GTGCTAAAACTG-3′; reverse, 5′-CA
TTAGGCACGTTACCATCAAATT
-3′; and probe, 5′-TAGGAACRCGT
GGCACCAACCAA-3′. Using this 
more specifi c and sensitive assay, we 
detected viral RNA in 63% of the rectal 
swabs tested; other CoVs including 
FIPV, severe acute respiratory 
syndrome–CoV, and human CoV NL-
63, were not amplifi ed by this assay (data 
not shown). All samples that had tested 
positive in the ORF1-CoV PCR were 
confi rmed positive with this TaqMan 
assay. To analyze FRCoV in ferrets 
from geographically distinct sites, we 
tested fecal samples from 90 animals 
without signs of disease (including 
epizootic catarrhal enteritis) from 39 
different locations in the Netherlands. 
FRCoV nucleocapsid TaqMan and 
ORF1-CoV PCR demonstrated that 
61% of the fecal samples and 72% of 
the locations were positive. Multiple 
testing of fecal swabs at different times 
and use of FRCoV-specifi c antibody 
assays would probably further increase 
the FRCoV prevalence rate.
Further partial sequence analysis 
of the spike gene by using primers
5′-AARRTTAATGAGTGTGTGMG
DTCA-3′ and 5′- CAACTCTYTTAA
GCCARTCAAGG-3′ clearly showed 
that these viruses are more closely 
related to systemic FRCoVs than 
to FRECV (Figure). Amino acid 
alignment of 1 of these sequences 
(FRCoV-511c) with FRECV-MSU2 
demonstrated 78% identity and 89% 
similarity, and FRCoV-511c shows 
86% identity and 92% similarity to 
FRSCV-MSU1.
After identifi cation of severe 
acute respiratory syndrome CoV in 
humans in 2003 and related viruses 
in civet cats and bats, an increase in 
CoV surveillance in different animal 
species resulted in identifi cation and 
characterization of a broad range of 
previously unrecognized CoVs (8). 
Here we report an enteric FRCoV 
circulating in the Netherlands in a 
high percentage of asymptomatic 
ferrets. The ferrets tested did not 
have a previous record of foul-
smelling green diarrhea described 
previously to be associated with 
FRECV, a virus detected in the United 
States and further characterized 
in 2006 (2). On the basis of the 
phylogenetic analysis of the spike 
sequences, FRECV-MSU2 might 
have evolved through recombination 
with some other unknown CoV. 
Alternatively, the viruses isolated in 
the Netherlands grouped more closely 
with FRCoVs causing systemic 
disease (e.g., FRSCV-MSU1). Thus 
far, no evidence indicates that the 
animals testing positive for the 
enteric CoV showed clinical disease 
that pointed to pyogranulomatous 
infl ammation, necrosis with or 
without perivasculitis, and vasculitis 
in abdominal and visceral organs 
associated with the systemic variant. 
Further genetic characterization of 
these enteric FRCoVs variants might 
show genetic differences that could 
explain the apparent pathotypes of 
these 2 FRCoVs. FRCoVs might 
evolve through mutation or deletion 
into viruses that cause systemic 
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disease, or alternatively, different 
FRCoVs are circulating, analogous to 
the hypotheses put forward to explain 
the occurrence of FIP (9,10). Given 
the use of ferrets in testing effi cacy 
of infl uenza virus vaccines and the 
propensity of CoVs to cross species 
barriers, further surveillance and 
investigation of the biology of these 
emerging FRCoVs is warranted.
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Figure. Phylogenetic tree based on nucleotide sequences of the nucleocapsid (A) and spike 
gene (B) of ferret coronaviruses (FRCoVs) 4E98 (GenBank accession nos. JF260916 and 
JF260914, respectively) and 511c (accession nos. JF260915 and JF260913, respectively) 
and other coronaviruses (CoVs). Partial nucleotide sequences were aligned by using 
ClustalX (www.clustal.org) and a neighbor-joining Kimura 2-parameter model with 1,000 
bootstrap replicates; avian CoVs were used as outgroup sequences (p-distance; allowing 
gaps or missing data). Other CoVs shown (abbreviation, GenBank accession number): 
ferret coronavirus (FRECV MSU2, GU338457); ferret systemic coronavirus (FRSCV 
MSU1, GU338456); feline coronavirus (FCoV, DQ010921); canine coronavirus (CCoV, 
AY342160); transmissible gastroenteritis virus (TGEV, AF104420); human coronavirus 
(HCoV NL63, DQ445911); porcine epidemic diarrhea virus (PEDV, AF353511); severe 
acute respiratory syndrome coronavirus (SARS-HCoV, NC_004718); murine hepatitis virus 
(MHV, AY700211); bovine coronavirus (BCoV, U00735); infectious bronchitis virus (IBV, 
AY363968); and turkey coronavirus (TuCov, AF111997). Scale bars indicate nucleotide 
substitutions per site.
